Home/Filings/4/0001179110-19-011289
4//SEC Filing

Abrams Judith R 4

Accession 0001179110-19-011289

CIK 0001650664other

Filed

Oct 29, 8:00 PM ET

Accepted

Oct 30, 4:16 PM ET

Size

7.1 KB

Accession

0001179110-19-011289

Insider Transaction Report

Form 4
Period: 2019-10-28
Abrams Judith R
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2019-10-28+150,000150,000 total
    Exercise: $21.61Exp: 2029-10-27Common Stock (150,000 underlying)
  • Award

    Common Stock

    2019-10-28+25,00025,000 total
Footnotes (2)
  • [F1]The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years in equal yearly installments of one-fourth of the shares, with the first such installment to vest on October 28, 2020 continuing through October 28, 2023.
  • [F2]This option was granted on October 28, 2019 and is scheduled to vest over four years, with 25% of the shares to vest on October 28, 2020 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through October 28, 2023.

Issuer

Editas Medicine, Inc.

CIK 0001650664

Entity typeother

Related Parties

1
  • filerCIK 0001697499

Filing Metadata

Form type
4
Filed
Oct 29, 8:00 PM ET
Accepted
Oct 30, 4:16 PM ET
Size
7.1 KB